EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advancements in bone malignancy research through next-generation sequencing focussed on osteosarcoma, chondrosarcoma, and Ewing sarcoma

Naveen Jeyaraman, Madhan Jeyaraman, Preethi Subramanian, Swaminathan Ramasubramanian, Sangeetha Balaji, Sathish Muthu, Ramya Lakshmi Rajendran, Prakash Gangadaran

Pathology - Research and Practice · 2025

DOI: 10.1016/j.prp.2025.155908 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2025. Verfasst von Naveen Jeyaraman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, ACS Medical College and Hospital, Dr MGR Educational and Research Institute, Chennai, Tamil Nadu 600077, India; Departmen…. Hauptthemen laut MEDLINE: Bone Neoplasms, Sarcoma, Ewing, High-Throughput Nucleotide Sequencing, Osteosarcoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Next-generation sequencing (NGS) technologies have revolutionized bone cancer research, enabling detailed insights into the genetic, transcriptional, and epigenetic layers of these malignancies. This overview discusses the pivotal role of NGS in enhancing the diagnosis, prognosis, and treatment of primary bone cancers such as osteosarcoma, chondrosarcoma, and Ewing sarcoma. By facilitating the identification of novel genetic mutations, gene fusions, and epigenetic alterations, NGS supports the development of personalized medicine approaches and targeted therapies, significantly impacting clinical outcomes. The utilization of various NGS platforms, including Illumina, SOLiD, and Ion Torrent, has provided comprehensive genomic profiles that inform targeted treatment strategies and enable early detection through liquid biopsies and circulating tumor DNA (ctDNA) analysis. Despite the profound clinical benefits, the integration of NGS into routine practice faces challenges such as technical limitations, complex data interpretation, and substantial infrastructure requirements. Future directions involve technological improvements, combinatorial omics approaches, and extensive validation through clinical trials to confirm the efficacy of NGS-guided interventions. These advancements promise to further enhance the precision and effectiveness of bone cancer management, offering hope for more tailored and effective therapeutic outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone NeoplasmsSarcoma, EwingHigh-Throughput Nucleotide SequencingOsteosarcomaChondrosarcomaHumansPrecision MedicineBiomarkers, Tumor

Stichwörter der Autor:innen

Bone cancerGenetic mutationsLiquid biopsyNext-generation sequencingPersonalized medicineTargeted therapy

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Orthopaedics, ACS Medical College and Hospital, Dr MGR Educational and Research Institute, Chennai, Tamil Nadu 600077, India; Department of Research Methods, Orthopaedic Research Group, Coimbatore, Tamil N…
  • Department of Radiation Oncology, Apollo Proton Cancer Centre, Chennai, Tamil Nadu 600041, India.
  • Department of Orthopaedics, Government Medical College, Omandurar Government Estate, Chennai, Tamil Nadu 600002, India.
  • Department of Biotechnology, Faculty of Engineering, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu 641021, India; Department of Orthopaedics, Government Medical College, Karur, Tamil Nadu 639004, India.
  • Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea; Cardiovascular Research Institute, Kyungpook National University, Daegu 41944, Republic of Korea; BK21 F…

Zitieren

APA

Jeyaraman, N., Jeyaraman, M., Subramanian, P., Ramasubramanian, S., Balaji, S., Muthu, S., Rajendran, R. L., & Gangadaran, P. (2025). Advancements in bone malignancy research through next-generation sequencing focussed on osteosarcoma, chondrosarcoma, and Ewing sarcoma. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2025.155908

Vancouver

Jeyaraman N, Jeyaraman M, Subramanian P, Ramasubramanian S, Balaji S, Muthu S, et al. Advancements in bone malignancy research through next-generation sequencing focussed on osteosarcoma, chondrosarcoma, and Ewing sarcoma. Pathology - Research and Practice. 2025. doi:10.1016/j.prp.2025.155908

BibTeX
@article{Jeyaraman2025,
  author = {Jeyaraman, Naveen and Jeyaraman, Madhan and Subramanian, Preethi and Ramasubramanian, Swaminathan and Balaji, Sangeetha and Muthu, Sathish and Rajendran, Ramya Lakshmi and Gangadaran, Prakash},
  title = {Advancements in bone malignancy research through next-generation sequencing focussed on osteosarcoma, chondrosarcoma, and Ewing sarcoma},
  journal = {Pathology - Research and Practice},
  year = {2025},
  doi = {10.1016/j.prp.2025.155908}
}
Kostenlos starten →